InsiderTrades

Form 4 for IDXX Idexx Laboratories

Accepted 2023-11-08 00:00:00 ET · period of report 2023-11-07 · accession 0000874716-23-000131 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-11-08 2023-11-07 IDXX Lane Michael EVP M - OptEx $133.76 +1,728 5,214 +50% +$231.1K
DM 2023-11-08 2023-11-07 IDXX Lane Michael EVP M - OptEx $0.00 -1,728 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-07 M A 560 $178.26 5,773.99 D — —
2 Common Common Stock 2023-11-07 M A 462 $67.85 4,507.99 D — — (F1) Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023.
3 Common Common Stock 2023-11-07 M A 706 $141.60 5,213.99 D — —
4 Derivative Incentive Stock Option (right-to-buy) 2023-11-07 M D 706 $0.00 0 D $141.60 · — to 2027-02-13 706 Common Stock (F4) Grant of option to buy 706 shares of Issuer common stock that vested ion the fifth anniversary of the date of grant.
5 Derivative Incentive Stock Option (right-to-buy) 2023-11-07 M D 560 $0.00 0 D $178.26 · — to 2028-02-13 560 Common Stock (F5) Grant of option to buy 560 shares of Issuer common stock that vested on the fifth anniversary of the date of grant.
6 Derivative Incentive Stock Option (right-to-buy) 2023-11-07 M D 462 $0.00 0 D $67.85 · — to 2026-02-13 462 Common Stock (F3) Grant of option to buy 2,072 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021.